CoChat

Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vivo

Open access
Chen, Y.P., Hsiao, P.J., Hong, W.S., Dai, T.Y., Chen, M.J. · 2012 · Journal of Dairy Science
Cited by 110

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Lactobacillus kefiranofaciens M1, isolated from and identified in Taiwanese milk kefir grain, has demonstrated immune-modulating activity. In the present study, we further investigated the effects of Lb. kefiranofaciens M1 on intestinal epithelial cells in vitro and on dextran sodium sulfate (DSS)-induced colitis in vivo. The possible mechanisms regarding the cytokine products and intestinal epithelial barrier restoration as well as the putative receptor for the protective effects of Lb. kefiranofaciens M1 were investigated. In vitro results indicated that Lb. kefiranofaciens M1 could strengthen the epithelial barrier function in vitro by increasing the transepithelial electrical resistance (TEER) and significantly upregulated the level of the chemokine CCL-20 at both the apical and basolateral sites. The in vivo effects of Lb. kefiranofaciens M1 on the regulation of intestinal physiology indicate that this strain could ameliorate DSS-induced colitis with a significant attenuation of the bleeding score and colon length shortening. Production of proinflammatory cytokines was decreased and that of the antiinflammatory cytokine IL-10 was increased in the DSS-treated mice given Lb. kefiranofaciens M1. The putative receptor for the protective effects of Lb. kefiranofaciens M1 was toll-like receptor 2 (TLR2), which was involved in probiotic-induced cytokine production in vitro and in attenuation of the bleeding score and colon length shortening in vivo. In this study, the kefir lactobacillus Lb. kefiranofaciens M1 clearly demonstrated an anticolitis effect. Based on these results, Lb. kefiranofaciens M1 has the potential to be applied in fermented dairy products as an alternative therapy for intestinal disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3168/jds.2011-4696

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 44

  1. Agle, 2010, Calcium mobilization triggered by the chemokine CXCL12 regulates migration in wounded intestinal epithelial monolayers, J. Biol. Chem., 285, 16066, 10.1074/jbc.M109.061416 · DOI
  2. Anderson, 2010, Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function, FEMS Microbiol. Lett., 309, 184
  3. Araki, 2006, In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis, Oncol. Rep., 16, 1357
  4. Caballero-Franco, 2007, The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells, Am. J. Physiol. Gastrointest. Liver Physiol., 292, G315, 10.1152/ajpgi.00265.2006 · DOI · Paper page
  5. Cai, 2010, Live and lyophilized Lactobacillus species elicit differential immunomodulatory effects on immune cells, FEMS Microbiol. Lett., 302, 189, 10.1111/j.1574-6968.2009.01853.x · DOI
  6. Cario, 2004, Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C, Gastroenterology, 127, 224, 10.1053/j.gastro.2004.04.015 · DOI · Paper page
  7. Castagliuolo, 2005, Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice, FEMS Immunol. Med. Microbiol., 43, 197, 10.1016/j.femsim.2004.08.011 · DOI · Paper page
  8. Chen, 2008, Microbiological study of lactic acid bacteria in kefir grains by culture-dependent and culture-independent methods, Food Microbiol., 25, 492, 10.1016/j.fm.2008.01.003 · DOI · Paper page
  9. Chen, 2009, Therapeutic effects of four strains of probiotics on experimental colitis in mice, World J. Gastroenterol., 15, 321, 10.3748/wjg.15.321 · DOI · Paper page
  10. Fajdiga, 2006, Interference of Salmonella enteritidis and Lactobacillus spp. with IL-8 levels and transepithelial electrical resistance of enterocyte-like Caco-2 cells, Folia Microbiol. (Praha), 51, 268, 10.1007/BF02931810 · DOI
  11. Fitzpatrick, 2008, In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: Immunomodulation and attenuation of murine colitis, Br. J. Nutr., 100, 530, 10.1017/S0007114508930373 · DOI
  12. Geier, 2007, Inflammatory bowel disease: Current insights into pathogenesis and new therapeutic options: Probiotics, prebiotics and synbiotics, Int. J. Food Microbiol., 115, 1, 10.1016/j.ijfoodmicro.2006.10.006 · DOI · Paper page
  13. Gibson, 2008, Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis, Cell. Microbiol., 10, 388
  14. Herías, 2005, Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice, Int. J. Food Microbiol., 103, 143, 10.1016/j.ijfoodmicro.2004.11.032 · DOI
  15. Hoarau, 2008, Supernatant from Bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells, PLoS ONE, 3, e2753, 10.1371/journal.pone.0002753 · DOI · Paper page
  16. Hong, 2009, Effects of kefir supernant and lactic acid bacteria isolated from kefir grain on cytokine production by macrophage, Int. Dairy J., 19, 244, 10.1016/j.idairyj.2008.10.010 · DOI
  17. Johnson-Henry, 2008, Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function, Infect. Immun., 76, 1340, 10.1128/IAI.00778-07 · DOI · Paper page
  18. Kaji, 2010, Bacterial teichoic acids reserve predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages, J. Immunol., 184, 3505, 10.4049/jimmunol.0901569 · DOI · Paper page
  19. Kojouharoff, 1997, Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice, Clin. Exp. Immunol., 107, 353, 10.1111/j.1365-2249.1997.291-ce1184.x · DOI · Paper page
  20. Koninkx, 2010, Probiotic bacteria induced improvement of the mucosal integrity of enterocyte-like Caco-2 cells after exposure to Salmonella enteritidis 857, Funct. Foods, 2, 225, 10.1016/j.jff.2010.06.001 · DOI
  21. Li, 2003, Glutamine supports recovery from loss of transepithelial resitance and increase of permeability induced by media change in Caco-2 cells, J. Nutr. Biochem., 14, 401, 10.1016/S0955-2863(03)00071-8 · DOI
  22. Madsen, 2001, Probiotic bacteria enhance murine and human intestinal epithelial barrier function, Gastroenterology, 121, 580, 10.1053/gast.2001.27224 · DOI · Paper page
  23. Madsen, 1999, Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice, Gastroenterology, 116, 1107, 10.1016/S0016-5085(99)70013-2 · DOI · Paper page
  24. Marchiando, 2010, Epithelial barriers in homeostasis and disease, Annu. Rev. Pathol., 5, 119, 10.1146/annurev.pathol.4.110807.092135 · DOI · Paper page
  25. Meng, 2004, Antagonistic antibody prevent toll-like receptor 2-driven lethal shock-like syndromes, J. Clin. Invest., 113, 1473, 10.1172/JCI20762 · doi:10.1172/jci20762 · Paper page
  26. Mileti, 2009, Comparison of the immunomodulatory properties of three probiotic strains of lactobacilli using complex culture systems: Prediction for in vivo efficacy, PLoS ONE, 4, e7056, 10.1371/journal.pone.0007056 · DOI · Paper page
  27. Miyauchi, 2009, Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo, J. Dairy Sci., 92, 2400, 10.3168/jds.2008-1698 · DOI · Paper page
  28. Nanda Kumar, 2008, Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate, J. Gastroenterol. Hepatol., 23, 1834, 10.1111/j.1440-1746.2008.05723.x · DOI · Paper page
  29. Neish, 2004, Molecular aspects of intestinal epithelial cell-bacterial interactions that determine the development of intestinal inflammation, Inflamm. Bowel Dis., 10, 159, 10.1097/00054725-200403000-00015 · DOI
  30. Obermeier, 1999, Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice, Clin. Exp. Immunol., 116, 238, 10.1046/j.1365-2249.1999.00878.x · DOI · Paper page
  31. Pronio, 2008, Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells, Inflamm. Bowel Dis., 14, 662, 10.1002/ibd.20369 · DOI · Paper page
  32. Rakoff-Nahoum, 2004, Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, Cell, 118, 229, 10.1016/j.cell.2004.07.002 · DOI · Paper page
  33. Reiff, 2009, Balancing inflammatory, lipid and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowe disease, Inflamm. Bowel Dis., 15, 1721, 10.1002/ibd.20999 · DOI · Paper page
  34. Reiff, 2010, Inflammatory bowel disease, gut bacteria and probiotic therapy, Int. J. Med. Microbiol., 300, 25, 10.1016/j.ijmm.2009.08.004 · DOI · Paper page
  35. Resta-Lenert, 2006, Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells, Gastroenterology, 130, 731, 10.1053/j.gastro.2005.12.015 · DOI · Paper page
  36. Schlee, 2008, Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2, Clin. Exp. Immunol., 151, 528, 10.1111/j.1365-2249.2007.03587.x · DOI · Paper page
  37. Sherman, 2005, Probiotics reduce enterohemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements, Infect. Immun., 73, 5183, 10.1128/IAI.73.8.5183-5188.2005 · DOI · Paper page
  38. Strober, 2002, The immunology of mucosal models of inflammation, Annu. Rev. Immunol., 20, 495, 10.1146/annurev.immunol.20.100301.064816 · DOI · Paper page
  39. Struyf, 2005, Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue, Eur. J. Immunol., 32, 1583, 10.1002/eji.200425753 · DOI
  40. Ulisse, 2001, Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: Effects of probiotic treatment, Am. J. Gastroenterol., 96, 2691, 10.1111/j.1572-0241.2001.04139.x · doi:10.1111/j.1572-0241.2001.04139.x · Paper page
  41. Vanderpool, 2008, Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel disease, Inflamm. Bowel Dis., 14, 1585, 10.1002/ibd.20525 · DOI · Paper page
  42. Voltan, 2008, Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-γ in the intestinal mucosa, Gastroenterology, 135, 1216, 10.1053/j.gastro.2008.07.007 · DOI
  43. Vongsa, 2009, CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells, J. Biol. Chem., 284, 10034, 10.1074/jbc.M805289200 · DOI
  44. Zyrek, 2007, Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair, Cell. Microbiol., 9, 804, 10.1111/j.1462-5822.2006.00836.x · DOI · Paper page

Cited by

Metadata

Authors
Chen, Y. P., Hsiao, P. J., Hong, W. S., Dai, T. Y., & Chen, M. J.
Venue
Journal of Dairy Science
Published
2012-01
Volume
95
Issue
1
Pages
63-74
ISSN
0022-0302 (ISSN-L)
OpenAlex
W2069214417
Cited by
110
References
12
FWCI
7.20
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.